1. Home
  2. HOWL vs LICN Comparison

HOWL vs LICN Comparison

Compare HOWL & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • LICN
  • Stock Information
  • Founded
  • HOWL 2017
  • LICN 2004
  • Country
  • HOWL United States
  • LICN China
  • Employees
  • HOWL N/A
  • LICN N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • LICN
  • Sector
  • HOWL Health Care
  • LICN
  • Exchange
  • HOWL Nasdaq
  • LICN Nasdaq
  • Market Cap
  • HOWL 53.4M
  • LICN 3.1M
  • IPO Year
  • HOWL 2021
  • LICN 2023
  • Fundamental
  • Price
  • HOWL $1.25
  • LICN $4.44
  • Analyst Decision
  • HOWL Strong Buy
  • LICN
  • Analyst Count
  • HOWL 3
  • LICN 0
  • Target Price
  • HOWL $8.33
  • LICN N/A
  • AVG Volume (30 Days)
  • HOWL 549.7K
  • LICN 24.5K
  • Earning Date
  • HOWL 08-07-2025
  • LICN 01-01-0001
  • Dividend Yield
  • HOWL N/A
  • LICN N/A
  • EPS Growth
  • HOWL N/A
  • LICN N/A
  • EPS
  • HOWL N/A
  • LICN N/A
  • Revenue
  • HOWL $1,143,000.00
  • LICN $41,477,000.00
  • Revenue This Year
  • HOWL N/A
  • LICN N/A
  • Revenue Next Year
  • HOWL N/A
  • LICN N/A
  • P/E Ratio
  • HOWL N/A
  • LICN N/A
  • Revenue Growth
  • HOWL N/A
  • LICN 4.32
  • 52 Week Low
  • HOWL $0.60
  • LICN $2.60
  • 52 Week High
  • HOWL $4.18
  • LICN $488.00
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 45.36
  • LICN 53.94
  • Support Level
  • HOWL $1.03
  • LICN $4.02
  • Resistance Level
  • HOWL $1.10
  • LICN $4.41
  • Average True Range (ATR)
  • HOWL 0.07
  • LICN 0.25
  • MACD
  • HOWL -0.02
  • LICN 0.05
  • Stochastic Oscillator
  • HOWL 22.81
  • LICN 92.57

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: